Comparison · NCT01377402-7e5c21ec
Cardiovascular Death vs Myocardial Re-infarction: Participants With Cardiac Events During Follow-up.
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Cardiovascular Death vs Myocardial Re-infarction: Participants With Cardiac Events During Follow-up. Trial comparisons, record NCT01377402-7e5c21ec. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01377402-7e5c21ec
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0937 | 0.077 | 0.114 | wilson | |
| Risk in group 2 | 0.0519 | 0.0397 | 0.0676 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0418 | 0.0188 | 0.0651 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.8 | 1.3 | 2.51 | log | |
| Odds ratio, group 1 over group 2 | 1.89 | 1.32 | 2.69 | log | |
| Number needed to treat, for one more participant with the outcome on Cardiovascular Death than on Myocardial Re-infarction | 24 | 15.4 | 53.1 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Cardiovascular Death | Patients with confirmed cardiovascular death during the course of the study | 92 | 982 | OG000 |
| Group 2 | Myocardial Re-infarction | Patients with one or more myocardial re-infarctions during the course of the study | 51 | 982 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Participants With Cardiac Events During Follow-up.
- Description
- Cardiovascular Death. Myocardial infarctions (re-MIs) defined according to WHO criteria of 1979.
- Time frame
- 2-5 years
- Population
Source ClinicalTrials.gov
Trial
- Title
- ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study
- NCT number
- NCT01377402
- Phases
- Conditions
- Chest Pain, Coronary Artery Disease, Unstable Angina Pectoris, Myocardial Infarction
- Interventions
- Lead sponsor
- Helse Stavanger HF
- Results first posted
- 2015-12-17
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01377402?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01377402-7e5c21ec